Condensed Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 4,241,710	$ 2,965,512
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(15,284)	(18,335)
Offering costs allocated to warrants		438,287
Change in fair value of warrant liability	(4,657,458)	(3,683,625)
Changes in operating assets and liabilities:
Prepaid expense	(20,755)	(219,171)
Accrued expenses	(127,487)	75,203
Due to related party	385,963	131,886
Net cash used in operating activities	(193,311)	(310,243)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(151,742,500)
Net cash used in investing activities		(151,742,500)
Cash Flows from Financing Activities:
Proceeds from issuance of Units, net of underwriting discount		146,510,000
Proceeds from issuance of Private Placement Warrants		7,057,500
Proceeds from promissory note – related party		10,800
Repayment of promissory note – related party		(152,251)
Payment of offering costs		(307,640)
Net cash provided by financing activities		153,118,409
Net change in cash	(193,311)	1,065,666
Cash, beginning of period	194,034	34
Cash, end of the period	$ 723	1,065,700
Supplemental disclosure of cash flow information:
Initial classification of warrant liability		15,026,525
Deferred underwriters’ discount payable charged to additional paid-in-capital		$ 5,232,500